GE HealthCare Technologies (GEHC) Q4 Earnings and Revenues Beat Estimates

分组1 - GE HealthCare Technologies (GEHC) reported quarterly earnings of $1.44 per share, exceeding the Zacks Consensus Estimate of $1.43 per share, but down from $1.45 per share a year ago, resulting in an earnings surprise of +1.00% [1] - The company achieved revenues of $5.7 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.87%, compared to $5.32 billion in the same quarter last year [2] - GE HealthCare has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has underperformed the market, losing about 4% since the beginning of the year, while the S&P 500 has gained 1.1% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $1.02 on $5 billion in revenues, and for the current fiscal year, it is $4.94 on $21.38 billion in revenues [7] 分组3 - The Zacks Industry Rank indicates that the Medical - Products sector is currently in the bottom 34% of over 250 Zacks industries, which may negatively impact stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, suggesting that tracking these revisions can be beneficial for investors [5] - The estimate revisions trend for GE HealthCare was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6]